Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

43
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
43
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

706
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
706
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

1.9K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

613
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
613
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

263
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
263

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Redefining Uric Acid and Cardiovascular Risk: Vascular Gout and Crystal-Driven Vascular Inflammation in Asymptomatic Hyperuricemia.

JACC. Asia·2026
Same author

Barriers and Associated Factors to Writing Case Reports Among Japanese General Medicine Physicians: A Cross-Sectional Study of the Japan Primary Care Association Members.

Journal of general and family medicine·2026
Same author

Big Data Analyses Using Health Care Records Can Reveal Epidemiologic Features of Kawasaki Disease in Japan: A Study Based on the National Database of Health Insurance Claims.

Journal of epidemiology·2026
Same author

Soluble uric acid enhances gouty inflammation via activating gene expression related to innate immune responses, M1 macrophage polarization and urate crystal phagocytosis in mouse macrophage-like cells: novel insights into its mechanisms from RNA sequencing.

Hypertension research : official journal of the Japanese Society of Hypertension·2026
Same author

Differential associations of transient hyperuricemia and transient hypouricemia with annual changes in estimated glomerular filtration rate in healthy participants: an observational study.

BMC nephrology·2026
Same author

Endothelial cell-released CD93 contributes to podocyte injury in idiopathic nephrotic syndrome.

Science translational medicine·2026

相关实验视频

Updated: May 28, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.3K

高尿路血,一种新的心血管风险.

Masanari Kuwabara1, Ichiro Hisatome2, Ryusuke Ae3

  • 1Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University Tochigi, Japan; Department of Cardiology, NHO Yonago Medical Center, Tottori, Japan.

Nutrition, metabolism, and cardiovascular diseases : NMCD
|February 12, 2025
PubMed
概括

高尿酸水平 (超尿血) 与心血管疾病有关. 虽然降低尿酸可能会降低风险,但目前对诸如丁氧化酶抑制剂等疗法的证据尚不确定,需要进一步研究.

关键词:
无症状的高尿路血症.心血管疾病是什么心血管疾病这是一种痛风,痛风.风险因素 风险因素 风险因素尿酸是什么 尿酸是什么

更多相关视频

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

19.4K

相关实验视频

Last Updated: May 28, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.3K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

19.4K

科学领域:

  • 心血管医学 心血管医学
  • 代谢障碍 代谢障碍 代谢障碍
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 高尿路血是心血管疾病的重要危险因素,包括高血压和心力衰竭.
  • 尿酸水平升高会导致炎症和氧化应激,影响细胞过程.
  • 超尿血和心血管事件之间的联系已经得到了很好的证实,特别是在痛风患者中.

研究的目的:

  • 审查高尿血和心血管疾病之间的关联.
  • 探索尿酸降低疗法在缓解心血管事件中的有效性.
  • 讨论患者的结果和针对性治疗的需要.

主要方法:

  • 关于PubMed来源的综合文献审查.
  • 流行病学研究和干预试验的分析.
  • 对丁氧化酶抑制剂 (例如,阿洛普林醇,费布克索斯塔特) 的评估.

主要成果:

  • 观察到高尿血和不良心血管结果之间存在一致的相关性.
  • 用丁氧化酶抑制剂进行的干预试验在减少心血管事件方面产生了不同的结果.
  • 尿酸水平的性别差异被发现,这表明可能需要进行性别特异性风险评估.

结论:

  • 超尿血和心血管疾病之间的关联得到了证据的强烈支持.
  • 目前关于尿酸降低治疗对心血管事件的益处的证据是不确定的.
  • 未来的研究应该专注于针对高风险患者的个性化治疗策略.